[1] |
WANG Zhiqing, LIU Xiyu, FAN Lei.
Advances and controversies in the adjuvant treatment of early breast cancer
[J]. China Oncology, 2025, 35(3): 255-262.
|
[2] |
LU Yufeng, WANG Han, XIE Yifan, JIANG Yizhou, SHAO Zhimin.
Significant fundamental translational research on breast cancer in China: progress and prospects
[J]. China Oncology, 2025, 35(2): 143-153.
|
[3] |
YANG Xin, SHI Qianfeng, LIU Qiang.
Progress of important clinical research on breast cancer in China in 2024
[J]. China Oncology, 2025, 35(2): 167-175.
|
[4] |
LI Xing, PENG Ziqi, YU Xinmiao, JIN Feng.
Important research progress in clinical practice for early breast cancer in 2024
[J]. China Oncology, 2025, 35(2): 176-185.
|
[5] |
WANG Ting, QIN Yi, XU Xiaowu, YU Xianjun.
New advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2024
[J]. China Oncology, 2025, 35(1): 1-11.
|
[6] |
HAO Xian, HUANG Jianjun, YANG Wenxiu, LIU Jinting, ZHANG Junhong, LUO Yubei, LI Qing, WANG Dahong, GAO Yuwei, TAN Fuyun, BO Li, ZHENG Yu, WANG Rong, FENG Jianglong, LI Jing, ZHAO Chunhua, DOU Xiaowei.
Establishment of primary breast cancer cell line as new model for drug screening and basic research
[J]. China Oncology, 2024, 34(6): 561-570.
|
[7] |
CHEN Hong, CAO Zhiyun.
Recent progress in the construction and application of patient-derived pancreatic cancer organoid models
[J]. China Oncology, 2024, 34(6): 590-597.
|
[8] |
QIAN Bin, CHEN Haiquan.
Important progress in surgical treatment of lung cancer in 2023
[J]. China Oncology, 2024, 34(4): 335-339.
|
[9] |
FENG Zheng, GUO Qinhao, ZHU Jun, WU Xiaohua, WEN Hao.
Progress in treatment of gynecological cancer in 2023
[J]. China Oncology, 2024, 34(4): 340-360.
|
[10] |
XU Yonghu, XU Dazhi.
Progress and prospects of gastric cancer treatment in the 21st century
[J]. China Oncology, 2024, 34(3): 239-249.
|
[11] |
WANG Xuefei, ZHOU Peng, TANG Zhaoqing.
New progress and development trend of surgical treatment for gastric cancer
[J]. China Oncology, 2024, 34(3): 250-258.
|
[12] |
ZHANG Qi, XIU Bingqiu, WU Jiong.
Progress of important clinical research of breast cancer in China in 2023
[J]. China Oncology, 2024, 34(2): 135-142.
|
[13] |
ZHANG Siyuan, JIANG Zefei.
Important research progress in clinical practice for advanced breast cancer in 2023
[J]. China Oncology, 2024, 34(2): 143-150.
|
[14] |
WANG Zhaobu, LI Xing, YU Xinmiao, JIN Feng.
Important research progress in clinical practice for early breast cancer in 2023
[J]. China Oncology, 2024, 34(2): 151-160.
|
[15] |
REN Jiaqiang, WU Shuai, SU Tong, LI Jie, HAN Liang, WU Zheng.
An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
[J]. China Oncology, 2024, 34(12): 1090-1099.
|